These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 25485838)

  • 41. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours.
    Miao H; Wang L; Gong F; Duan L; Wang L; Yao Y; Feng M; Deng K; Wang R; Xiao Y; Ling Q; Zhu H; Lu L
    Clin Endocrinol (Oxf); 2024 Jul; 101(1):32-41. PubMed ID: 38691659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PATHOGENESIS OF CUSHING DISEASE: AN UPDATE ON THE GENETICS OF CORTICOTROPINOMAS.
    Albani A; Perez-Rivas LG; Reincke M; Theodoropoulou M
    Endocr Pract; 2018 Oct; 24(10):907-914. PubMed ID: 30084690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
    Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
    Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells.
    Jian FF; Li YF; Chen YF; Jiang H; Chen X; Zheng LL; Zhao Y; Wang WQ; Ning G; Bian LG; Sun QF
    Chin Med J (Engl); 2016 Sep; 129(17):2102-8. PubMed ID: 27569239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease.
    Kawashima ST; Usui T; Sano T; Iogawa H; Hagiwara H; Tamanaha T; Tagami T; Naruse M; Hojo M; Takahashi JA; Shimatsu A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):656-7. PubMed ID: 18771563
    [No Abstract]   [Full Text] [Related]  

  • 47. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome.
    Cohen M; Persky R; Stegemann R; Hernández-Ramírez LC; Zeltser D; Lodish MB; Chen A; Keil MF; Tatsi C; Faucz FR; Buchner DA; Stratakis CA; Tiosano D
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4676-4682. PubMed ID: 31162547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
    Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
    Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A heterozygous germline deletion within USP8 causes severe neurodevelopmental delay with multiorgan abnormalities.
    Sakamoto M; Kurosawa K; Tanoue K; Iwama K; Ishida F; Watanabe Y; Okamoto N; Tsuchida N; Uchiyama Y; Koshimizu E; Fujita A; Misawa K; Miyatake S; Mizuguchi T; Matsumoto N
    J Hum Genet; 2024 Feb; 69(2):85-90. PubMed ID: 38030753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paediatric Cushing's disease - a literature review of epidemiology, pathogenesis, clinical symptoms, and diagnostics.
    Pasternak-Pietrzak K; Moszczyńska E; Jurkiewicz E; Szalecki M
    Endokrynol Pol; 2020; 71(1):87-95. PubMed ID: 32129467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
    Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
    Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to Letter to the Editor from Lasolle and Raverot: "USP8 and TP53 Drivers Are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors".
    Uzilov AV; Geer EB
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3293-e3294. PubMed ID: 33822973
    [No Abstract]   [Full Text] [Related]  

  • 55. Novel Drop-off PCR Assay for USP8 Hotspot Variant Detection in Corticotroph Tumors.
    Miranda RL; Guterres A; de Azeredo Lima CH; Lamback E; Gadelha MR
    Endocr Pathol; 2024 Sep; 35(3):269-271. PubMed ID: 39230646
    [No Abstract]   [Full Text] [Related]  

  • 56. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel Genetic Causes of Pituitary Adenomas.
    Caimari F; Korbonits M
    Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter to the Editor From Helene Lasolle and Gérald Raverot: "USP8 and TP53 Drivers Are Associated With CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors".
    Lasolle H; Raverot G
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3285-e3286. PubMed ID: 33822961
    [No Abstract]   [Full Text] [Related]  

  • 60. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
    Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.